Stockreport

Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 [Seeking Alpha]

Fennec Pharmaceuticals Inc.  (FENC) 
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.fennecpharma.com/investor-relations
PDF This drug helps reduce cisplatin-induced ototoxicity in pediatric patients who are battling cancer. Pedmark is FDA-approved for pediatric patients =1 month, and it ha [Read more]